These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22477728)

  • 1. Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.
    Bezabeh S; Mackey AC; Kluetz P; Jappar D; Korvick J
    Oncologist; 2012; 17(4):550-4. PubMed ID: 22477728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors.
    Hall JJ; Bolina M; Chatterley T; Jamali F
    Ann Pharmacother; 2017 Feb; 51(2):163-178. PubMed ID: 27701081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
    Johnson DA; Chilton R; Liker HR
    Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.
    Wedemeyer RS; Blume H
    Drug Saf; 2014 Apr; 37(4):201-11. PubMed ID: 24550106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database.
    Suzuki Y; Suzuki H; Umetsu R; Uranishi H; Abe J; Nishibata Y; Sekiya Y; Miyamura N; Hara H; Tsuchiya T; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(5):680-6. PubMed ID: 25947914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(5):322-6. PubMed ID: 22745572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
    Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K
    Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.
    Kwok CS; Loke YK
    Drug Saf; 2012 Feb; 35(2):127-39. PubMed ID: 22204719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of possible pharmacokinetic interaction between methotrexate and proton pump inhibitors in rats.
    Ueda H; Narumi K; Sato Y; Furugen A; Kobayashi M; Iseki K
    Pharmacol Rep; 2020 Oct; 72(5):1426-1432. PubMed ID: 32671657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.
    Farhat N; Haddad N; Crispo J; Birkett N; McNair D; Momoli F; Wen SW; Mattison DR; Krewski D
    Eur J Clin Pharmacol; 2019 Feb; 75(2):227-235. PubMed ID: 30324301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Proton Pump Inhibitors and Microscopic Colitis.
    Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
    Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancytopenia Due to Possible Drug-Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors.
    Tao D; Wang H; Xia F; Ma W
    Drug Healthc Patient Saf; 2022; 14():75-78. PubMed ID: 35607639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
    Ranchon F; Vantard N; Henin E; Bachy E; Sarkozy C; Karlin L; Bouafia-Sauvy F; Gouraud A; Schwiertz V; Bourbon E; Baudouin A; Caffin AG; Vial T; Salles G; Rioufol C
    Hematol Oncol; 2018 Apr; 36(2):399-406. PubMed ID: 28983943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.
    Reeves DJ; Moore ES; Bascom D; Rensing B
    Br J Clin Pharmacol; 2014 Sep; 78(3):565-71. PubMed ID: 24646036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy.
    Suzuki K; Doki K; Homma M; Tamaki H; Hori S; Ohtani H; Sawada Y; Kohda Y
    Br J Clin Pharmacol; 2009 Jan; 67(1):44-9. PubMed ID: 19076159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
    Norgard NB; Mathews KD; Wall GC
    Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors: Risk for Myopathy?
    Colmenares EW; Pappas AL
    Ann Pharmacother; 2017 Jan; 51(1):66-71. PubMed ID: 27539734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.